June 14, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
CHICAGO — At 2 years, crinecerfont demonstrated favorable effects on weight, body composition and insulin resistance in adults with congenital adrenal hyperplasia, researchers reported at ENDO 2026.
June 14, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Lundbeck presents new Phase II asedebart data in Cushing's disease at ENDO 2026

Published Study Shows Clinically Significant Energy, Performance, and Metabolic Benefits of FutureCeuticals' Caffinity™

Darren Candow: Creatine may have anti-cancer benefits, supports child development with daily intake, and enhances athletic performance through energy production | The Diary of a CEO